# JenaValve Technology

**Canonical:** https://apis.io/providers/jenavalve-technology/  
**Website:** https://jenavalve.com/  
**APIs profiled:** 7

JenaValve Technology, Inc. is a privately held medical-device company headquartered at 4 Cromwell, Irvine, California, with an EU headquarters in the Central Tower, Landsberger Str. 110, Munich and a UK office at Unit 9A Astley Way, Swillington, Leeds. Founded in 2006 on a concept developed in 1995 by Professors Hans Figulla and Markus Ferrari, it develops the Trilogy Heart Valve System, a transcatheter aortic valve replacement (TAVR) device purpose-built for the minimally invasive treatment of severe aortic regurgitation (AR) as well as aortic stenosis (AS), delivered transfemorally and transapically with a porcine pericardial valve. The system carries a CE mark and is an investigational device in the United States, supported by the ALIGN-AR and ARTIST clinical studies and the JENA-VAD registry. The company has raised roughly $364 million across 13 rounds from investors including Bain Capital Life Sciences, the Qatar Investment Authority, Pictet Alternative Advisors, Innovatus Capital Partners and Peijia Medical. JenaValve operates no developer API programme — there is no developer portal, no API documentation, no keys, no SDKs, no CLI, no MCP server, no agent card, no changelog and no status page, and no developer, api, docs, status or trust subdomain resolves. Its two corporate WordPress sites do each serve an anonymously readable REST API, and on both of them the standard content collections are wide open while the administrative routes are correctly locked to 401.

## Kin Score — 33.4 / 100 (thin)

Scored 2026-08-12 under rubric 0.11.0. Trend: flat (+0.0 from 33.4).

| Facet | Score |
|---|---|
| Discoverability | 92.6 |
| Contract Quality | 53.4 |
| Governance | 11.5 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 27.7 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 31.3 (matched via tags).

## Agent readiness — 33.6 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | yes |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## APIs (7)

- **JenaValve Technology Authors API** — Public author profiles attached to published content.
- **JenaValve Technology Content API** — The AR education library — posts, pages and site search.
- **JenaValve Technology Discovery API** — Route and capability discovery documents.
- **JenaValve Technology Media API** — Uploaded media library items.
- **JenaValve Technology O Embed API** — oEmbed provider endpoint for discover-ar.com URLs.
- **JenaValve Technology SEO API** — Yoast SEO head-metadata endpoint.
- **JenaValve Technology Taxonomy API** — The articles / videos / audio / presentations category taxonomy.

## Security (2)

- **Jenavalve Technology Authentication** — none/http · 2 schemes
- **Jenavalve Technology Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Medical Devices, Healthcare, Cardiology, Structural Heart, TAVR, Aortic Regurgitation, Aortic Stenosis, Heart Valves, Clinical Trials, Patient Education, Private Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/jenavalve-technology/). Scores are computed from the provider's own public artifacts under a published rubric.